{"text": ["Health", "Care", "Sector", "Update", "for", "02/12/2018:", "AXON,UTHR,NVO,FOLD,AVEO"], "created_at": "2018-02-12 19:26:54"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/12/2018:", "AXON,UTHR,NVO,FOLD,AVEO"], "created_at": "2018-02-12 19:26:54"}
{"text": ["Noteworthy", "ETF", "Outflows:", "VEU,", "TD,", "SAP,", "NVO"], "created_at": "2018-02-12 18:08:18"}
{"text": ["Noteworthy", "ETF", "Outflows:", "VEU,", "TD,", "SAP,", "NVO"], "created_at": "2018-02-12 18:08:18"}
{"text": ["Blog", "Exposure", "-", "Novo", "Nordisk\u2019s", "Ozempic", "is", "Approved", "in", "the", "EU", "for", "the", "Treatment", "of", "Type", "2", "Diabetes"], "created_at": "2018-02-12 12:10:00"}
{"text": ["GlaxoSmithKline", "plc", "--", "Moody's:", "M&A", "greatest", "downside", "risk", "to", "European", "pharma", "companies'", "credit", "quality", "in", "2018"], "created_at": "2018-02-12 10:31:08"}
{"text": ["Better", "Buy:", "Pfizer", "Inc.", "(PFE)", "vs.", "Eli", "Lilly", "(LLY)"], "created_at": "2018-02-12 05:06:16"}
{"text": ["Better", "Buy:", "Pfizer", "Inc.", "(PFE)", "vs.", "Eli", "Lilly", "(LLY)"], "created_at": "2018-02-12 05:06:16"}
